glutathione iv parkinson& 39 Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease Glutathione—a review on its role

86 KaplanM

L-Glutathione khng ch gip lm trng da m cn ng vai tr quan trng trong vic xy dng v thanh lc cc t bo, bo v gan khi c t v lm chm qu trnh lo ha t nhin. Nhng cng dng ni bt ca L-Glutathione i vi sc khe v ln da Lm trng sng v chng lo ha da L-Glutathione c bit n rng ri nh mt chin binh chng li qu trnh lo ha da

However, there is a small subset of patients that does not obey this pattern, displaying median expression of NRF2 and low expression of KEAP1 red dots (NRF2-KEAP1 alteration) indicating a higher activity of the transcription factor in those tumors

Peptide Protocols The real value of peptide therapy, according to Koniver, is not in individual peptides but in how they are combined